diabetic foot ulcers (DFU) looks to be the next trial to get underway.
$9.6B market just for DFU, other wound applications could follow.
Clinicians and parties connected to TekCyte look extremely excited by this trial from recent promotion.
Sounds like formalisation of the licensing deal and trial commencement is imminent.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $46.30M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $30.89K | 162.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29641 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 111465 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| CYP (ASX) Chart |